Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy manufacturing
Fierce Pharma
FDA delays decision on Orca Bio’s cell therapy for blood cancers
The delay comes at a time when the biopharma industry is highly attuned to FDA actions on cell and gene therapies after a string of regulatory surprises.
Angus Liu
Apr 1, 2026 8:00am
Fierce Pharma
AZ to build cell therapy supply hub, R&D center in Shanghai
Mar 19, 2026 10:20am
As CAR-T gains ground on solid tumors, red tape blocks progress
Feb 26, 2026 3:08pm
Charles River sells CDMO and discovery assets in strategic pivot
Feb 25, 2026 1:54pm
Charles River's incoming CEO talks R&D processes, reorg goals
Jan 28, 2026 12:58pm
Fierce Pharma
J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T
Nov 12, 2025 11:36am
